Zai Lab Ltd. is a biopharmaceutical company, which engages in the developing and commercializing therapies that address medical conditions with unmet needs in oncology, autoimmune disorders, infectious diseases, and neuroscience. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2020-09-28. The firm is committed to addressing the unmet medical needs in the fields of tumors, autoimmune diseases, infectious diseases and central nervous system diseases through product discovery, development and commercialization. The firm has a series of patented drug candidates from the discovery stage to the late clinical project. These include ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others.
What is the price performance of Zai Lab Limited stock?
The current price of Zai Lab Limited is $18.37, it has decreased 1.28% in the last trading day.
What are the primary business themes or industries for Zai Lab Limited?
Zai Lab Limited belongs to Biotechnology industry and the sector is Health Care
What is Zai Lab Limited market cap?
Zai Lab Limited's current market cap is $2.0B
Is Zai Lab Limited a buy, sell, or hold?
According to wall street analysts, 10 analysts have made analyst ratings for Zai Lab Limited, including 2 strong buy, 8 buy, 3 hold, 0 sell, and 2 strong sell